Recent health news highlights include China's approval of the first commercial brain-computer interface device, GSK's ...
Recent health developments include China's approval of a brain-computer interface device, expanded age range for GSK's RSV vaccine by the US FDA, and Stryker's operations disrupted by a cyberattack.
Zacks Investment Research on MSN
GSK's RSV vaccine Arexvy wins FDA nod for high-risk younger adults
GSK plc GSK announced that the FDA approved the expanded use of its adjuvanted recombinant respiratory syncytial virus (RSV) vaccine, Arexvy, in adults aged 18 to 49 years who are at a higher risk of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results